Author

Dhiraj P. Sonawane

Cleveland ClinicORCID 0000-0002-0177-9568Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Cancer Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:drug response / drug discovery· 1 Approach:experimental assay· 1 Organism:human· 1 Assay:proteomics· 1

Frequent Co-Authors

A. Abigail Lindsey· 1 shared Amit Kumar GuptaiD· 1 shared Annabella Rico· 1 shared Anthony R. SloaniD· 1 shared Christopher G. HubertiD· 1 shared Christopher M. GoinsiD· 1 shared Emma G. Rico· 1 shared Feixiong ChengiD· 1 shared

Activity by Year

2026-2026 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperCancer Biology

A. Abigail Lindsey

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

Development and Characterization of Triazole-Based WDR5 Inhibitors for the Treatment of Glioblastoma

Jesse A. Coker, Steven R. Martinez, Sang Hoon Han, Anthony R. Sloan, Amit Kumar Gupta, George Bukenya, Paul M. Polzer, James H. Ramos, Emma G. Rico, Annabella Rico, A. Abigail Lindsey, Tanvi Navadgi, Natalie Reitz, Todd Romigh, Jonathan Macdonald, , Shaun R. Stauffer

This study develops triazole-based WDR5 inhibitors that show improved brain penetration and antiproliferative activity against glioblastoma CSCs, with synergistic effects when combined with ATAD2 inhibitors.

JCI Insight · May 5, 2026Peer-reviewedCancer Biology